DE3669106D1 - Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. - Google Patents

Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.

Info

Publication number
DE3669106D1
DE3669106D1 DE8686109256T DE3669106T DE3669106D1 DE 3669106 D1 DE3669106 D1 DE 3669106D1 DE 8686109256 T DE8686109256 T DE 8686109256T DE 3669106 T DE3669106 T DE 3669106T DE 3669106 D1 DE3669106 D1 DE 3669106D1
Authority
DE
Germany
Prior art keywords
flavanolignanes
pharmaceutical compositions
compositions containing
phospholipides
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686109256T
Other languages
English (en)
Inventor
Ezio Bombardelli
Maria Jose Magistretti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDB Holding SpA
Original Assignee
Inverni Della Beffa SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11184200&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3669106(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inverni Della Beffa SpA filed Critical Inverni Della Beffa SpA
Application granted granted Critical
Publication of DE3669106D1 publication Critical patent/DE3669106D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8686109256T 1985-07-17 1986-07-07 Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. Expired - Fee Related DE3669106D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21603/85A IT1187687B (it) 1985-07-17 1985-07-17 Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi

Publications (1)

Publication Number Publication Date
DE3669106D1 true DE3669106D1 (de) 1990-04-05

Family

ID=11184200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686109256T Expired - Fee Related DE3669106D1 (de) 1985-07-17 1986-07-07 Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.

Country Status (6)

Country Link
EP (1) EP0209037B1 (de)
JP (1) JPS6222719A (de)
AT (1) ATE50499T1 (de)
CS (1) CS261637B1 (de)
DE (1) DE3669106D1 (de)
IT (1) IT1187687B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190370B (it) * 1985-06-19 1988-02-16 Zambon Spa Composizione farmaceutica solida per uso orale
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
DE4401902C2 (de) * 1994-01-24 2000-02-03 Madaus Ag Verwendung von Flavolignanen als Adjuvans in der Tumortherapie
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
CN1061239C (zh) * 1995-01-20 2001-01-31 李叔文 爱滋病特效治疗剂
US6979459B1 (en) 2000-04-06 2005-12-27 Perricone Nicholas V Treatment of skin damage using polyenylphosphatidycholine
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
US6932963B2 (en) 2000-06-23 2005-08-23 Nicholas V. Perricone Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
DE60220415T2 (de) 2001-07-27 2008-02-14 Neptune Technologies & Bioressources Inc., Laval Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
ATE350047T1 (de) * 2001-10-25 2007-01-15 Vladimir Leko Zusammensetzung zum schutz und zur regeneration von leberstruktur und -funktion
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
RU2283114C1 (ru) * 2005-06-07 2006-09-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Композиция, обладающая гепатопротекторной активностью и нормализующая обменные процессы
WO2010150051A1 (de) * 2009-06-24 2010-12-29 Lipoid Gmbh Zusammensetzung für kosmetische, pharmazeutische oder diätetische anwendungen
JP5827625B2 (ja) 2009-10-29 2015-12-02 アカスティ ファーマ インコーポレイテッド 濃縮治療用リン脂質組成物
CN105816422B (zh) 2015-01-05 2020-08-14 天士力医药集团股份有限公司 一种水飞蓟宾注射剂及其制备方法
CN105983013A (zh) * 2015-03-23 2016-10-05 天士力制药集团股份有限公司 一种含有水飞蓟宾、葛根提取物的药物组合物
CN105983016B (zh) 2015-03-23 2023-08-11 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合
ITUB20155532A1 (it) * 2015-11-12 2017-05-12 St Biochimico Italiano Giovanni Lorenzini Spa Formulazione farmaceutica orale comprendente silibina
EP3703724A1 (de) 2017-11-02 2020-09-09 NatureCeuticals Sdn. Bhd. Extrakt aus orthosiphon stamineus, formulierungen und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5060M (de) * 1965-12-22 1967-05-08
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees

Also Published As

Publication number Publication date
CS261637B1 (en) 1989-02-10
IT8521603A0 (it) 1985-07-17
EP0209037B1 (de) 1990-02-28
EP0209037A1 (de) 1987-01-21
CS545686A1 (en) 1988-07-15
IT1187687B (it) 1987-12-23
JPS6222719A (ja) 1987-01-30
ATE50499T1 (de) 1990-03-15

Similar Documents

Publication Publication Date Title
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
HUP0100430A2 (hu) Strukturált glicerideket tartalmazó készítmény, valamint alkalmazása zsíroldékony vegyületek felszívódásának fokozására
ATE522211T1 (de) Stabilisierte fibrat-mikropartikel
MY118371A (en) Tetrahydrolipstatin containing compositions
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ATE226815T1 (de) Herstellung von arzneimitteln
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
BR0108435A (pt) Formulação e uso de entecavir de baixa dose
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ATE223204T1 (de) Liposomenzusammensetzung
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
ATE80295T1 (de) Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
IT1314199B1 (it) Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
ITMI910133A1 (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ATE220325T1 (de) Pharmazeutische verwendungen von zypressen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: I D B HOLDING S.P.A., MAILAND/MILANO, IT

8339 Ceased/non-payment of the annual fee